Concepedia

Myriam Delaunay

MD

8

Publications

945

Citations

8

H-Index

2017

Active since

Affiliations

Inserm(Current)

Hôpital Larrey

Institut Claudius Regaud

Centre de Recherche en Cancérologie de Toulouse

Université Toulouse III - Paul Sabatier

Myriam Delaunay is an author at Inserm specializing in lung cancer, radiation oncology, and medicine.

Top concepts

Publications per year

2017–2023

8

Publications

8

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

Myriam Delaunay, J. Cadranel, Amélie Lusque et al. · European Respiratory Journal · 2017 · 416 citations · Full text

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab

Nicolas Guibert, Myriam Delaunay, Amélie Lusque et al. · Lung Cancer · 2018 · 225 citations

, , +8

Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer

Nicolas Guibert, Greg Jones, John F. Beeler et al. · Lung Cancer · 2019 · 101 citations · Full text

, , +10

Monitoring of <i>KRAS</i>-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma

Nicolas Guibert, Julien Mazières, Myriam Delaunay et al. · Oncotarget · 2017 · 88 citations · Full text

Immune Checkpoint Inhibitors Rechallenge Efficacy in Non–Small-Cell Lung Cancer Patients

Élisa Gobbini, Anne Claire Toffart, M. Pérol et al. · Clinical Lung Cancer · 2020 · 69 citations · Full text

, , +9

Rows per page

1–5 of 8